OverviewChartNewsTraderScreen

L&S Knock-Out EVT 12.12.2024/  DE000LX4HCG7  /

EUWAX
11/8/2024  6:09:47 PM Chg.-0.020 Bid10:00:23 PM Ask10:00:23 PM Underlying Strike price Expiration date Option type
0.410EUR -4.65% -
Bid Size: -		 -
Ask Size: -		 EVOTEC SE INH O.N. 3.50 EUR 12/12/2024 Call
GlobeNewswire 5/14 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 12/11/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 11/7/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 8/20/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 2/7/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2/7/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2/15/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 1/8/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 9/14/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 11/29/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 11/10/2011 Evotec reports nine months results: Upside materialising
GlobeNewswire 11/3/2011 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 10/27/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 10/20/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 10/5/2011 Evotec announces second multi-target collaboration with UCB
GlobeNewswire 9/29/2011 Evotec acquires remaining 30% of Indian Joint Venture from DIL
GlobeNewswire 9/9/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 9/5/2011 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire 9/5/2011 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire 8/18/2011 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire 8/11/2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire 8/11/2011 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire 8/4/2011 Evotec to Report Second Quarter 2011 Results on 11 August 2011
GlobeNewswire 7/7/2011 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire 6/30/2011 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...